Department of Medicine and Emory Health Services Research Center, Emory University School of Medicine, 1750 Haygood Drive #250-N, Atlanta, GA, USA.
Center for Methods On Implementation and Prevention Science, Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
Implement Sci. 2024 Nov 19;19(1):77. doi: 10.1186/s13012-024-01403-6.
Ethical issues arise in the context of implementation science that may differ from those encountered in other research settings. This report, developed out of a workshop convened by the Center for Translation Research and Implementation Science within the United States National Heart, Lung, and Blood Institute, identifies six key themes that are important to the assessment of ethical dimensions of implementation science. First, addressing ethical challenges in implementation science does not require new ethical principles, commitments, or regulations. However, it does require understanding of the specific contexts arising in implementation research related to both study design and the intervention being implemented. Second, implementation research involves many different types of people in research, including patients, clinicians, administrators, the social networks of any of these, and the general population. These individuals play different roles that may entail different ethical considerations, obligations, and vulnerabilities. Third, the appropriateness of and need for informed consent in implementation research is connected to the role of the subject/participant, the nature of the intervention, and the design of the study. Even where traditional "full" consent processes are unnecessary or inappropriate, communication and engagement are critical. Similarly, even when research is exempt and informed consent unnecessary, Data Safety and Monitoring Board oversight of implementation studies may be advisable to ensure quality, address unexpected consequences, and identify overwhelming evidence of benefit. Fourth, implementation science is often explicitly designed to encourage specific behaviors and discourage others. There is a need for clarity regarding when efforts at behavioral change enhance or threaten autonomy and how to protect participants whose autonomy is threatened. Fifth, there is significant overlap between implementation science and quality improvement, and the ideal regulatory oversight structure for implementation science remains unclear. It is critical to encourage learning and growth while assuring appropriate protections. Sixth, implementation research takes place across a range of social and cultural contexts. Engagement and collaboration with stakeholders in designing and executing implementation trials and studies- especially when vulnerabilities exist- is essential. Attention to these themes will help ensure that implementation science fulfills its goal of advancing the practice of health care within a sound ethical framework.
伦理问题在实施科学中出现,可能与其他研究环境中遇到的问题不同。本报告由美国国家心肺血液研究所翻译研究与实施科学中心组织的一次研讨会制定,确定了六个重要主题,这些主题对于评估实施科学的伦理维度至关重要。首先,解决实施科学中的伦理挑战并不需要新的伦理原则、承诺或法规。然而,它确实需要了解在与研究设计和实施干预相关的实施研究中出现的具体情况。其次,实施研究涉及研究中的许多不同类型的人,包括患者、临床医生、管理人员、这些人的社交网络以及一般人群。这些人扮演着不同的角色,可能涉及不同的伦理考虑、义务和脆弱性。第三,实施研究中知情同意的适当性和必要性与研究对象/参与者的角色、干预措施的性质以及研究设计有关。即使在不需要或不适当的传统“完整”同意过程的情况下,沟通和参与也至关重要。同样,即使研究是豁免的,不需要知情同意,实施研究的数据安全和监测委员会监督也可能是明智的,以确保质量,解决意外后果,并确定压倒性的受益证据。第四,实施科学通常是为了明确鼓励特定的行为,同时劝阻其他行为。在努力改变行为增强或威胁自主权的情况下,以及在如何保护自主权受到威胁的参与者方面,需要明确性。第五,实施科学与质量改进之间存在很大的重叠,实施科学的理想监管监督结构仍不清楚。鼓励学习和成长的同时确保适当的保护至关重要。第六,实施研究发生在一系列社会和文化背景下。在设计和执行实施试验和研究时,与利益相关者进行接触和合作——特别是在存在脆弱性的情况下——是至关重要的。关注这些主题将有助于确保实施科学在健全的伦理框架内实现其推进医疗保健实践的目标。